These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8915311)

  • 41. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
    Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
    JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertension in children with neurofibromatosis.
    Virdis R; Balestrazzi P; Zampolli M; Donadio A; Street M; Lorenzetti E
    J Hum Hypertens; 1994 May; 8(5):395-7. PubMed ID: 8064789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of systematic ophthalmologic investigations in neurofibromatosis 1: a cross-sectional study of 211 patients.
    Arigon V; Binaghi M; Sabouret C; Zeller J; Revuz J; Soubrane G; Wolkenstein P
    Eur J Ophthalmol; 2002; 12(5):413-8. PubMed ID: 12474925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population.
    Vagge A; Camicione P; Capris C; Sburlati C; Panarello S; Calevo MG; Traverso CE; Capris P
    Acta Ophthalmol; 2015 Dec; 93(8):e667-71. PubMed ID: 25990002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Neurofibromatosis type 1: more frequent and severe then usually thought].
    Souza JF; Toledo LL; Ferreira MC; Rodrigues LO; Rezende NA
    Rev Assoc Med Bras (1992); 2009; 55(4):394-9. PubMed ID: 19750304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical management of neurofibromatosis 1: a cross-sectional study of 383 patients.
    Drappier JC; Khosrotehrani K; Zeller J; Revuz J; Wolkenstein P
    J Am Acad Dermatol; 2003 Sep; 49(3):440-4. PubMed ID: 12963907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neurofibromatosis 1: recommendations for management].
    Pinson S; Créange A; Barbarot S; Stalder JF; Chaix Y; Rodriguez D; Sanson M; Bernheim A; d'Incan M; Doz F; Stoll C; Combemale P; Kalifa C; Zeller J; Teillac-Hamel D; Lyonnet S; Zerah M; Lacour JP; Guillot B; Wolkenstein P
    Arch Pediatr; 2002 Jan; 9(1):49-60. PubMed ID: 11865551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Routine roentgenography on 4,036 health screening patients in a private hospital out-patient clinic.
    Lee TK; Low CH
    Singapore Med J; 1986 Feb; 27(1):18-25. PubMed ID: 3715484
    [No Abstract]   [Full Text] [Related]  

  • 49. Cerebrovascular dysplasia in neurofibromatosis type 1.
    Cairns AG; North KN
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1165-70. PubMed ID: 18469031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A retrospective study of preadoption x-ray findings in young children at the Social Child Aid: value and limitations].
    Miquel A; Commeau A; Adamsbaum C; Kalifa G
    Ann Pediatr (Paris); 1992 May; 39(5):289-92. PubMed ID: 1616244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Imaging features of neurofibromatosis involving the urinary bladder].
    El Ounani F; Dafiri R
    J Radiol; 2010 May; 91(5 Pt 1):567-9. PubMed ID: 20657356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of screening tests in children with neurofibromatosis type 1 (NF1).
    Baudou E; Chaix Y
    Childs Nerv Syst; 2020 Oct; 36(10):2311-2319. PubMed ID: 32524181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.
    Arch Neurol; 1988 May; 45(5):575-8. PubMed ID: 3128965
    [No Abstract]   [Full Text] [Related]  

  • 54. Annual review of children with neurofibromatosis type 1.
    Dunning-Davies BM; Parker AP
    Arch Dis Child Educ Pract Ed; 2016 Apr; 101(2):102-11. PubMed ID: 26486853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurofibromatosis: an overview and new directions in clinical investigations.
    Riccardi VM
    Adv Neurol; 1981; 29():1-9. PubMed ID: 6798831
    [No Abstract]   [Full Text] [Related]  

  • 56. Abdominal involvement in neurofibromatosis 1: sonographic findings.
    Sato M; Ishida H; Konno K; Komatsuda T; Hamashima Y; Naganuma H; Kon H; Watanabe S; Ishida J
    Abdom Imaging; 2000; 25(5):517-22. PubMed ID: 10931989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurofibromatosis presenting as an asymptomatic abdominal mass.
    Pimentel-Moreno AE; Rivera-Reyes L; Toro-Sola M
    Bol Asoc Med P R; 1982; 74(7-8):229-30. PubMed ID: 6820770
    [No Abstract]   [Full Text] [Related]  

  • 58. Scout film of the abdomen as a screening procedure in office patients.
    Gable JJ; Hicks MC
    Med Times; 1968 Jan; 96(1):19-24. PubMed ID: 5743714
    [No Abstract]   [Full Text] [Related]  

  • 59. Screening in neurofibromatosis type 1.
    O'Connor WJ
    Arch Dermatol; 1997 May; 133(5):655-6. PubMed ID: 9158424
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1.
    Al-Sharefi A; Javaid U; Perros P; Ealing J; Truran P; Nag S; Kamaruddin S; Abouglila K; Cains F; Lewis L; James RA
    Eur Endocrinol; 2019 Aug; 15(2):95-100. PubMed ID: 31616500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.